Patents for C12R 1 - Micro-organisms (92,025) |
---|
12/08/1992 | US5169835 Pregancy specific proteins applications |
12/08/1992 | US5169779 Enzyme catalyzing the transesterification of dextrorotatory enantiomer into insoluble form by adding acid, salt or ester derivative of butanol |
12/08/1992 | US5169767 Method of producing trehalose |
12/08/1992 | US5169760 Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters |
12/08/1992 | US5169755 Process for inducing cytochrome P-450 enzymes in streptomyces bacteria and determining the mutagenicity of chemicals |
12/08/1992 | US5169629 Process of controlling lepidopteran pests, using bacillus thuringiensis isolate denoted b.t ps81gg |
12/08/1992 | US5169628 Vaccines |
12/08/1992 | CA1311203C Dipeptidase, its isolation from lactic acid bacteria, antibodies against the dipeptidase, the use of the dipeptidase and of the antibodies against it |
12/08/1992 | CA1311192C Tumor specific assay for ca125 ovarian cancer antigen |
12/04/1992 | WO1992021979A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/04/1992 | CA2103142A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
12/04/1992 | CA2070242A1 Fermentation analogs of virginiamycin m1 |
12/04/1992 | CA2070233A1 Tetravalent bispecific receptors, the preparation and use thereof |
12/04/1992 | CA2070083A1 Process for the enzymatic preparation of cephalosporanic derivatives |
12/02/1992 | EP0516443A1 Vectors and methods for assaying the regulation of apolipoprotein ai synthesis |
12/02/1992 | EP0516306A2 Novel bacillus thuringiensis isolates active against hymenopteran pests and gene(s) encoding hymenopteran-active toxins |
12/02/1992 | EP0516286A1 Hepatitis B virus surface proteins with reduced host carbohydrate content |
12/02/1992 | EP0516190A2 Monoclonal antibodies, process for preparing them and their use |
12/02/1992 | EP0516156A1 Chemical modification of 2"-amino group in elsamicin A |
12/02/1992 | EP0516135A2 Human immunodeficiency virus-related immune preparation |
12/02/1992 | EP0515927A2 Pradimicin antibiotics |
12/02/1992 | EP0515569A1 Calcium channel compositions and methods |
12/02/1992 | EP0515516A1 Totally synthetic affinity reagents |
12/02/1992 | EP0515460A1 Docosahexaenoic acid, methods for its production and compounds containing the same |
12/02/1992 | EP0515394A1 COVALENT ANGIOGENIN/RNase HYBRIDS |
12/02/1992 | EP0496833A4 Biosynthetic constructs of tgf--g(b) |
12/02/1992 | CN1019302B Polycyclic ether antibioties |
12/01/1992 | US5168063 Strong binding of outer membrane protein; medical diagnosis |
12/01/1992 | US5168055 Fermentation and purification process for succinic acid |
12/01/1992 | US5168054 From oxidized unsaturated fatty acids |
12/01/1992 | US5168050 DNA constructs, mammalian expression vectors and host cells containing same |
12/01/1992 | US5168049 Production of streptavidin-like polypeptides |
12/01/1992 | US5168048 Penicillin G acylase, a gene encoding the same and a method for the production of this enzyme |
12/01/1992 | US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e |
12/01/1992 | US5167958 Culture products of Streptomyces resistomycificus |
12/01/1992 | CA2070058A1 Vectors and methods for assaying the regulation of apolipoprotein ai synthesis |
12/01/1992 | CA2069717A1 Chemical modification of 2"-amino group in elsamicin a |
12/01/1992 | CA2069671A1 Human immunodeficiency virus-related immune preparation |
12/01/1992 | CA2069361A1 Bioconversion process for the production of vanillin |
12/01/1992 | CA2067317A1 Caffeoyl-coa 3-o-methyltransferase genes |
12/01/1992 | CA1310927C Process for preparing algae having improved biological effects |
12/01/1992 | CA1310923C Dna encoding [asp --] and [lys -, asp --] thaumatin i |
12/01/1992 | CA1310921C Vector for the expression of fusion proteins and protein immunogens |
12/01/1992 | CA1310902C Autocrine motility factors in cancer diagnosis and management |
11/30/1992 | CA2068484A1 Pradimicin s antibiotics |
11/28/1992 | CA2069594A1 Recombinant avipox virus, culture of cells infected by this virus and fowl vaccines derived therefrom |
11/26/1992 | WO1992020811A2 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
11/26/1992 | WO1992020806A2 Dictyostelid expression vector and method for expressing a desired protein |
11/26/1992 | WO1992020803A1 THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
11/26/1992 | WO1992020799A1 Amino acid sequence of anticancer human monoclonal antibody and dna base sequence coding for the same |
11/26/1992 | WO1992020798A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿ |
11/26/1992 | WO1992020796A2 D-type cyclin and uses related thereto |
11/26/1992 | WO1992020795A1 INHIBITOR OF NF-λB TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF |
11/26/1992 | WO1992020794A1 Purification and cloning of p62 |
11/26/1992 | WO1992020792A1 Truncated forms of the hepatocyte growth factor (hgf) receptor |
11/26/1992 | WO1992020791A1 Methods for producing members of specific binding pairs |
11/26/1992 | WO1992020789A1 Process for obtaining dimethyl amine or trimethyl amine dehydrogenases, dehydrogenases obtained thereby and their use |
11/26/1992 | WO1992020785A1 Tumor associated monoclonal antibody 81av78 |
11/26/1992 | WO1992020782A1 Process for massive conversion of clostridia into synchronized cells of critical length or refractile endospores |
11/26/1992 | WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
11/26/1992 | WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
11/26/1992 | CA2109808A1 Process for massive conversion of clostridia into synchronized cells of critical length of refractile endospores |
11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression |
11/26/1992 | CA2108767A1 Tumor associated monoclonal antibody 81av78 |
11/26/1992 | CA2103376A1 Purification and cloning of p62 |
11/26/1992 | CA2103161A1 D-type cyclin and uses related thereto |
11/26/1992 | CA2103159A1 Cloning and expression of human islet glutamic acid decarboxylase autoantigen |
11/26/1992 | CA2102704A1 Inhibitor of nf-kb transcriptional activator and uses thereof |
11/26/1992 | CA2087339A1 Dictyostelid expression vector and method for expressing a desired protein |
11/25/1992 | EP0514884A1 Novel antibiotics MER-AF1032A and MER-AF1032B |
11/25/1992 | EP0514830A2 Methods and compositions of a preparation and use of a herpes protease |
11/25/1992 | EP0514494A1 Method for detection of human immunodeficiency virus and cell lines useful therefor. |
11/25/1992 | EP0514488A1 Retinoid receptor compositions and methods |
11/25/1992 | EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof |
11/25/1992 | EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19. |
11/25/1992 | EP0514411A1 Polypeptides and dna encoding same, associated with human malaria parasites |
11/25/1992 | EP0139676B1 Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins |
11/25/1992 | CN1066470A Process for producing monocyte chemotactic factor polypeptide and train for production thereof |
11/25/1992 | CA2331239A1 Structure, production and use of heregulin |
11/24/1992 | WO1992020229A1 Improved process for preparing coated microbial pesticides and pesticides produced therefrom |
11/24/1992 | US5166323 Acid hydrolysis of gluten to improve solubility, absorption and emulsifiers |
11/24/1992 | US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof |
11/24/1992 | US5166321 Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria |
11/24/1992 | US5166318 Anticoagulants |
11/24/1992 | US5166068 Method of culturing protoplasts |
11/24/1992 | US5166061 Process for the production of 4-halo-3-hydroxybutyronitrile with Corynebacterium or Microbacterium |
11/24/1992 | US5166060 Process for the preparation of pyridine-2,3-dicarboxylic acids |
11/24/1992 | US5166057 Templates for gene expression |
11/24/1992 | US5166055 Microbiological preparation of 9-alpha-hydroxy-17-keto steroids |
11/24/1992 | US5165931 Peptifluorin and neopeptifluorin |
11/24/1992 | US5165912 Reagents for diagnosis with antibodies reactive with enzymes |
11/24/1992 | CA2069199A1 Process for the clostripain-catalyzed linkage of arg-pro and arg-b (b=proteinogenous and non-proteinogenous amino acids) containing peptides |
11/24/1992 | CA1310601C Expression vectors |
11/24/1992 | CA1310572C Laminated structure comprising non-crosslinked foam as substrate |
11/23/1992 | CA2069147A1 Dna and its use |
11/21/1992 | CA2102292A1 The astrovirus human gastroenteritis agents and molecular cloning of corresponding cdnas |
11/19/1992 | EP0514207A2 Novel human neurokinin-1 receptor short form |
11/19/1992 | EP0513849A2 Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells |
11/19/1992 | EP0513778A2 Hybrid monoclonal antibodies and compositions containing them |
11/19/1992 | EP0513738A2 Serum-free medium for mammalian cells cultivation |